Faculty Opinions recommendation of Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial.

DOI

Metadata

Published
2014-08-29
DOI
  • 10.3410/f.718438655.793499231
Publisher
H1 Connect
Creator Name (e-Rad)
  • Vincent Emery

Related Articles

See more

Details 詳細情報について

Back to top